BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 179 filers reported holding BLUEBIRD BIO INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,255 | +8.1% | 11,450 | +4.6% | 0.00% | 0.0% |
| Q1 2023 | $36,307 | -64.3% | 10,950 | -25.5% | 0.00% | -62.5% |
| Q4 2022 | $101,610 | -97.1% | 14,690 | -67.4% | 0.01% | -97.3% |
| Q3 2022 | $3,538,000 | +8127.9% | 45,071 | +332.1% | 0.29% | +9633.3% |
| Q2 2022 | $43,000 | -24.6% | 10,430 | -11.8% | 0.00% | -25.0% |
| Q1 2022 | $57,000 | -58.7% | 11,830 | -14.5% | 0.00% | -55.6% |
| Q4 2021 | $138,000 | -89.5% | 13,830 | -69.4% | 0.01% | -89.8% |
| Q3 2021 | $1,310,000 | +92.4% | 45,234 | +766.4% | 0.09% | +95.6% |
| Q2 2021 | $681,000 | -41.7% | 5,221 | -83.7% | 0.04% | -45.8% |
| Q1 2021 | $1,168,000 | +276.8% | 32,023 | +930.7% | 0.08% | +295.2% |
| Q4 2020 | $310,000 | – | 3,107 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 82,500 | $5,090,000 | 4.20% |
| RTW INVESTMENTS, LP | 122,576 | $7,563,000 | 2.85% |
| Eventide Asset Management | 587,677 | $36,260,000 | 2.36% |
| First Light Asset Management, LLC | 71,246 | $4,396,000 | 1.93% |
| ARK Investment Management | 75,645 | $4,667,000 | 1.70% |
| Taylor Wealth Management Partners | 39,118 | $2,414,000 | 1.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 302,027 | $18,635,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 40,000 | $2,468,000 | 0.58% |
| Artal Group S.A. | 422,536 | $26,070,000 | 0.58% |
| Baillie Gifford | 5,164,467 | $318,647,000 | 0.52% |